2. Confirmation of CTEPH diagnosis by one of the following as recommended by standard guidelines:
* At least 1 (segmental) perfusion defect(s) in ventilation/perfusion (V/Q) scan or
* Pulmonary artery obstruction seen by MDCT (multidetector computed tomography) angiography or
* Pulmonary artery obstruction seen by conventional pulmonary cineangiography (In case of suspicion/diagnosis of 'sub-acute' Pulmonary Embolism: Patients who are treated with anti-coagulation for at least 3 months before diagnosis of CTEPH)
You may not be if
Patients with an underlying medical disorder with an anticipated life expectancy less than 6 months
Any medical condition which, in the opinion of the investigator, could jeopardize the safety of the patient or his/her compliance in the study, or otherwise make the patient inappropriate for study participation
Clareo Health | A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries